HTA172 Value of French Framework for Early Access Programs for the HTA Appraisal in the Rare Disease Spa The Example of Lanadelumab in Patients With Hereditary Angioedema
Abstract
Authors
N. Schmidely C. Chatelanaz C. Train C. Strub J. Delonca T. Marquet L. Bouillet O. Fain